|

LTZ-301 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • LTZ Therapeutics, Inc.1

Indications

  • Non-Hodgkin Lymphoma Refractory/ Relapsed1
  • Marginal Zone Lymphoma (MZL)1
  • Follicular Lymphoma ( FL)1
  • Mantle Cell Lymphoma (MCL)1
  • DLBCL - Diffuse Large B Cell Lymphoma1

Duarte, California1 trial

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

City of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.